268.87MMarket Cap
LossP/E TTM
Key Figures
86.520Open
90.400High
74.06KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
2.27%Turnover Ratio
85.190Prev. Close
82.250Low
2.89MTurnover
LossP/E Static
5.23P/B
0.00%Div Yield TTM
-18.63%ROA
97.97052wk High
1.37Volume Ratio
-10.58MNet Profit
3.27MShares
-2.1993EPS TTM
1.15Beta
-23.72%ROE
6.80052wk Low
9.57%Amplitude
100.00%Gross Margin
268.87MMarket Cap
2.34Reward/Risk
6.39%Risk Rate
Currency: USD Updated: 2026-07-31 Key Insights
Sol Gel Technologies Ltd's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 109 out of 385 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 193.00.In the medium term, the stock price is expected to trend up.Despite a good stock market performance and outperforming fundamentals over the past month, the technicals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Sol Gel Technologies Ltd's Score
Support & Resistance

Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Sol Gel Technologies Ltd Highlights
StrengthsRisks
Sol Gel Technologies Ltd News
More news coming soon, stay tuned...
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
Sol Gel Technologies Ltd
SLGL
4
Ionis Pharmaceuticals Inc
IONS
27
Kymera Therapeutics Inc
KYMR
24
Indicators
Financial Indicators
EPS

Relevant data have not been disclosed by the company yet.
Total revenue

Relevant data have not been disclosed by the company yet.
Sol Gel Technologies Ltd Info
Sol-Gel Technologies Ltd is a clinical-stage dermatology company. The Company is focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The Company’s offers a range of products twins, sirs-t, and vered. The Company is designed its proprietary, silica-based microencapsulation technology platform to enhance the tolerability and stability of topical drugs while maintaining their efficacy. Topical drugs often struggle to balance achieving both high efficacy and high tolerability. Its technology platform entraps active ingredients in an inert, inorganic silica shell, which creates an unnoticeable barrier between the active ingredient and the skin.
Ticker SymbolSLGL
CompanySol Gel Technologies Ltd
CEO
Websitehttp://www.sol-gel.com
Shareholders
FAQs
What is the current price of Sol Gel Technologies Ltd (SLGL)?
The current price of Sol Gel Technologies Ltd (SLGL) is 82.25.
What is the symbol of Sol Gel Technologies Ltd?
The ticker symbol of Sol Gel Technologies Ltd is SLGL.
What is the 52-week high of Sol Gel Technologies Ltd?
The 52-week high of Sol Gel Technologies Ltd is 97.97.
What is the 52-week low of Sol Gel Technologies Ltd?
The 52-week low of Sol Gel Technologies Ltd is 6.80.
What is the market capitalization of Sol Gel Technologies Ltd?
The market capitalization of Sol Gel Technologies Ltd is 268.87M.
Is Sol Gel Technologies Ltd (SLGL) currently rated as Buy, Hold, or Sell?
According to analysts, Sol Gel Technologies Ltd (SLGL) has an overall rating of Buy, with a price target of 193.00.
What is the Earnings Per Share (EPS TTM) of Sol Gel Technologies Ltd (SLGL)?
The Earnings Per Share (EPS TTM) of Sol Gel Technologies Ltd (SLGL) is -2.20.